CN1187073C - 一种治疗尖锐湿疣的药物组合物及其制备方法 - Google Patents
一种治疗尖锐湿疣的药物组合物及其制备方法 Download PDFInfo
- Publication number
- CN1187073C CN1187073C CNB021534608A CN02153460A CN1187073C CN 1187073 C CN1187073 C CN 1187073C CN B021534608 A CNB021534608 A CN B021534608A CN 02153460 A CN02153460 A CN 02153460A CN 1187073 C CN1187073 C CN 1187073C
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical composition
- podophyllotoxin
- salicylic acid
- radix sophorae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title claims description 12
- 229940079593 drug Drugs 0.000 title claims description 5
- 238000000034 method Methods 0.000 title claims description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 20
- 206010059313 Anogenital warts Diseases 0.000 claims abstract description 10
- YJGVMLPVUAXIQN-UHFFFAOYSA-N epipodophyllotoxin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YJGVMLPVUAXIQN-UHFFFAOYSA-N 0.000 claims abstract description 10
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 10
- YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 claims abstract description 10
- 229960001237 podophyllotoxin Drugs 0.000 claims abstract description 10
- YVCVYCSAAZQOJI-UHFFFAOYSA-N podophyllotoxin Natural products COC1=C(O)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YVCVYCSAAZQOJI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 10
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 9
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000012141 concentrate Substances 0.000 claims description 4
- -1 filtered Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 239000000890 drug combination Substances 0.000 claims 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 description 10
- 238000012360 testing method Methods 0.000 description 8
- 239000012895 dilution Substances 0.000 description 7
- 238000010790 dilution Methods 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000004500 asepsis Methods 0.000 description 5
- 208000019802 Sexually transmitted disease Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000006916 nutrient agar Substances 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000001572 anti-trichomonad Effects 0.000 description 3
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 208000001688 Herpes Genitalis Diseases 0.000 description 2
- 241000701074 Human alphaherpesvirus 2 Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- 201000004946 genital herpes Diseases 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000001473 noxious effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 238000002814 agar dilution Methods 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 208000003796 chancre Diseases 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021534608A CN1187073C (zh) | 2002-11-29 | 2002-11-29 | 一种治疗尖锐湿疣的药物组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021534608A CN1187073C (zh) | 2002-11-29 | 2002-11-29 | 一种治疗尖锐湿疣的药物组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1418685A CN1418685A (zh) | 2003-05-21 |
CN1187073C true CN1187073C (zh) | 2005-02-02 |
Family
ID=4752260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021534608A Expired - Lifetime CN1187073C (zh) | 2002-11-29 | 2002-11-29 | 一种治疗尖锐湿疣的药物组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1187073C (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1833674B (zh) * | 2006-01-11 | 2010-09-08 | 北京因科瑞斯生物制品研究所 | 一种疣迪凝胶及其制备方法 |
CN102048751B (zh) * | 2009-10-28 | 2013-05-15 | 邢淑艳 | 一种治疗尖锐湿疣的药物 |
CN103784946B (zh) * | 2014-02-16 | 2016-06-08 | 王海英 | 一种治疗尖锐湿疣的药物组合物 |
CN104971266B (zh) * | 2014-10-11 | 2018-05-29 | 淮安御传堂生物科技有限公司 | 一种治疗尖锐湿疣的中药水剂及其制备方法 |
CN108310072A (zh) * | 2018-02-07 | 2018-07-24 | 嘉善县圣康生物科技有限公司 | 一种去疣外用软膏药 |
-
2002
- 2002-11-29 CN CNB021534608A patent/CN1187073C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1418685A (zh) | 2003-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SaiRam et al. | Anti-microbial activity of a new vaginal contraceptive NIM-76 from neem oil (Azadirachta indica) | |
CN104082353A (zh) | 一种纯中药消毒剂及其制备方法 | |
CN1173820A (zh) | 治疗疱疹的药物组合物 | |
Soković et al. | Antifungal activity of the essential oils and components in vitro and in vivo on experimentally induced dermatomycoses at rats | |
CN109452320A (zh) | 母丁香挥发油的用途 | |
CN102948434A (zh) | 水产养殖杀菌祛虫剂 | |
CN1187073C (zh) | 一种治疗尖锐湿疣的药物组合物及其制备方法 | |
Tshibangu et al. | Chemical composition and bioactivity of Canarium schweinfurthii stem bark extracts from DR Congo against Sickle cell disease and associated bacteria | |
WO2008072988A1 (en) | Honey based compositions of a consistency that can be delivered to the respiratory system | |
CN104083433B (zh) | 治疗动物疥螨病的外用中兽药组合物、应用及其制备方法 | |
CN105012581A (zh) | 一种芦荟舒爽抑菌组合物、应用及其制备方法 | |
CN109287677A (zh) | 公丁香挥发油的用途 | |
Jian et al. | Evaluation of the in vitro acaricidal activity of ethanol extracts of seven Chinese medicinal herbs on Ornithonyssus sylviarum (Acari: Macronyssidae) | |
CN103550303B (zh) | 一种用于防治犬外耳炎的药物组合物 | |
Raghavendra et al. | Protective effect of partially purified 35 kDa protein from silk worm (Bombyx mori) fecal matter against carbon tetrachloride induced hepatotoxicity and in vitro anti-viral properties | |
Max et al. | Effect of crude root extract from Synadenium glaucescens on selected bacterial infections in albino mice (Mus musculus) | |
Sundaravadivelu et al. | Antimicrobial and anti-inflammatory response by two formulations of Jatyadithailam in healing diabetic foot ulcers | |
CN1426811A (zh) | 山苍子油在杀灭人畜体表寄生虫的作用 | |
CN108812707A (zh) | 一种杀蓟马植物精油组合物、制剂及其应用 | |
CN112516237A (zh) | 一种宠物用杀菌除臭喷雾剂及其制备方法 | |
WO2006029605A1 (de) | Verfahren und wirkstoff zur bekämpfung von plasmodien | |
CN105125536B (zh) | 治疗细菌、真菌、病毒或寄生虫引起的皮肤病的组合物 | |
CN101637470A (zh) | 一种防治痤疮的药物组合物及其应用 | |
Chakma et al. | Traditional uses of Ethno-medicinal Plants in Chittagong Hill Tracts (CHTs), Bangladesh: A Review | |
RU2780109C1 (ru) | Противовоспалительные глазные капли для домашних и сельскохозяйственных животных |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: QIYUANYIDE MEDICINES INST., BEIJING Free format text: FORMER OWNER: ZHANG HUIFANG Effective date: 20030812 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20030812 Address after: 100027, Beijing, Chaoyang District, East Third Ring Road, Xin 2, di Yang building, room 10, 1007A Applicant after: Beijing Qi Yuan Yi De Pharmaceuticals Research Center Address before: 100027, Beijing, Chaoyang District, East Third Ring Road, Xin 2, di Yang building, room 10, 1007A Applicant before: Zhang Huifang |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Guizhou Baixiang Pharmaceutical Co.,Ltd. Assignor: Beijing Qi Yuan Yi De Pharmaceuticals Research Center Contract fulfillment period: 2006.4.15 to 2013.4.15 Contract record no.: 2008990000875 Denomination of invention: Medicine composition for treating and its prepn. method Granted publication date: 20050202 License type: Exclusive license Record date: 20081022 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2006.4.15 TO 2013.4.15; CHANGE OF CONTRACT Name of requester: GUIZHOU BAIXIANG PHARMACEUTICAL CO. Effective date: 20081022 |
|
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Guizhou Baixiang Pharmaceutical Co.,Ltd. Assignor: Beijing Qi Yuan Yi De Pharmaceuticals Research Center Contract record no.: 2008990000875 Date of cancellation: 20111214 |
|
ASS | Succession or assignment of patent right |
Owner name: HANFANG PHARMACEUTICAL CO., LTD., GUIZHOU Free format text: FORMER OWNER: QIYUANYIDE MEDICINES INST., BEIJING Effective date: 20120223 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100027 CHAOYANG, BEIJING TO: 550002 GUIYANG, GUIZHOU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120223 Address after: Nanming District of Guiyang city in 550002 of the 45 South Road, building 19 floor Huakun development Patentee after: GUIZHOU HANFANG PHARMACEUTICAL Co.,Ltd. Address before: 100027, Beijing, Chaoyang District, East Third Ring Road, Xin 2, di Yang building, room 10, 1007A Patentee before: Beijing Qi Yuan Yi De Pharmaceuticals Research Center |
|
TR01 | Transfer of patent right |
Effective date of registration: 20190329 Address after: 550029 Jinyang Science and Technology Industrial Park, Guiyang High-tech Industrial Development Zone, Guizhou Province (No. 11 Duyun Road) Patentee after: HANFANG PHARMA CO.,LTD. Address before: 19 Floor, Huakun Development Building, 45 South China Road, Nanming District, Guiyang City Patentee before: GUIZHOU HANFANG PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Medicine composition for treating and its prepn. method Effective date of registration: 20200519 Granted publication date: 20050202 Pledgee: Guizhou mingdekang Technology Center (L.P.) Pledgor: HANFANG PHARMA Co.,Ltd. Registration number: Y2020520000006 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220428 Granted publication date: 20050202 Pledgee: Guizhou mingdekang Technology Center (L.P.) Pledgor: HANFANG PHARMA CO.,LTD. Registration number: Y2020520000006 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
CX01 | Expiry of patent term |
Granted publication date: 20050202 |
|
CX01 | Expiry of patent term |